Fumiya Kadoriku
Papers
6
Total Citations
29
H-Index
3
About
Dr. Fumiya Kadoriku is a pioneering urologic surgeon whose research focuses on advancing minimally invasive surgical techniques for bladder and kidney cancers, particularly in older and high-risk patient populations. His work centers on robot-assisted radical cystectomy (RARC) and partial nephrectomy, with a special emphasis on optimizing urinary diversion methods. Dr. Kadoriku’s most impactful study, a 2022 propensity score matching analysis (14 citations), demonstrated that intracorporeal ileal conduit and cutaneous ureterostomy (CUS) are viable options for older patients undergoing RARC, challenging traditional preferences for open surgery. He further refined this work in a 2024 multicenter comparative study, showing that robotic CUS offers superior perioperative outcomes over open surgery. His 2024 analysis of robot-assisted partial nephrectomy in younger versus older adults with renal cell carcinoma (5 citations) provides critical evidence for age-adapted surgical decision-making. Notably, his 2025 collaborative study on the “radical cystectomy-pentafecta” after neoadjuvant chemotherapy (4 citations) establishes a new benchmark for quality in bladder cancer surgery. With over 29 citations across his key papers, Dr. Kadoriku’s research is shaping the future of robotic urologic oncology, making complex procedures safer and more accessible for vulnerable patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6